Mamta Kalra
Vice President Process and Analytical Development, Immatics
Mamta Kalra is listed as Vice President Process and Analytical Development, Immatics. Mamta is scheduled to speak at Advanced Therapies Week 2027 on 19 January 2027.
Compiled from published conference agendas; not yet confirmed by Mamta. Is this you? Claim this profile.
About
Mamta Kalra, PhD, is Vice President of Process and Analytical Development at Immatics, with over 15 years of experience in cell and gene therapy. Since joining Immatics in 2016, she has helped advance ACTengine® and next-generation TCR-T programs. Her expertise spans process and analytical development, viral vectors, potency strategies, comparability, validation and regulatory CMC. She leads teams advancing T-cell therapies from early clinical development through late-stage development and commercial readiness, connecting scientific innovation with robust, scalable and cost-efficient manufacturing. Mamta holds a PhD in Immunology from the Postgraduate Institute of Medical Education and Research, India, and completed postdoctoral training in adoptive T-cell therapy at Baylor College of Medicine.
Upcoming
Advanced Therapies Week 2027 19 January 2027 – 21 January 2027
- Panel: The benchtop bottleneck: Solving the scalable processing shortage Speaker · 19 January 2027
- Session 1: Autologous and allogeneic cell therapies – what’s the latest progress in reducing process timeframes and cost of goods while enhancing scalability, quality, and consistency? Speaker · 19 January 2027
- Session 2: Which process and analytical tools have the requisite flexibility, scalability, and cost-effectiveness to enable rapid clinical translation while laying the groundwork for later development and commercialization? Part 2 Speaker · 19 January 2027
- Spotlight: Building reliable, scalable and cost-efficient TCR-T manufacturing Speaker · 19 January 2027
Spoke alongside
People who have shared a session with Mamta at events on B2DB.
- Josh Sorafine Senior Vice President Quality and Analytics · Editas Medicine 2 shared sessions
- Damian Marshall VP - Analytical Development · Resolution Therapeutics 1 shared session
- Greg Russotti Chief Technology & Manufacturing Officer · Century Therapeutics 1 shared session
- Isabel Tian Senior Director, Scientific Affairs · Cellares 1 shared session
- Jeffrey Cram Vice President of Process Development · Elevatebio 1 shared session
- Sarah Yuan Chief Technology Officer · Cabaletta Bio 1 shared session